Kalkine Media On November 4, 2026, FMR LLC and Abigail P. Johnson submitted Amendment No. 3 to their Schedule 13G filing with the SEC, reporting their beneficial ownership of Roblox Corp Class A Common Stock as of September 30, 2026. Through Amendment No. 3 to Schedule 13G, FMR LLC…
Yahoo Finance Oops, something went wrong U.S. markets open in 7h 8m Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and…
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EyePoint, Inc. ("EyePoint" or the "Company") (NASDAQ: EYPT). Such investors are... NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of EyePoint, Inc. ("EyePoint" or…
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 795 outpatient physical therapy clinics in 45 states. Its reportable segments include the Physi... U.S. Physical Therapy, Inc. Stock Healthcare…
Kalkine Media On November 5, 2026, FMR LLC submitted Amendment No. 2 to its Schedule 13G filing with the SEC, reporting a beneficial ownership stake in Caris Life Sciences Inc. as of September 30, 2026. FMR LLC and Abigail P. Johnson’s Amendment No. 2 to Schedule 13G reveals a…
Thermo Fisher Scientific Inc. announced that Michael D. Shafer, Executive Vice President of the Company, will retire effective December 31, 2026.... Thermo Fisher Scientific, Inc. Advanced Medical Equipment & Technology Thermo Fisher Scientific Inc. Announces Retirement of Michael D. Shafer as Executive Vice President, Effective…
6:00 a.m. Nov 6, 2026 [For more diverse corporate information on startups featured in this article, please visit the Unicorn Factory Big Data Platform 'Data Lab'.] ━1,330 Support Projects, 100 Technology Holding Companies, Yet Modest Results━ Nevertheless, commercialization results have fallen short of expectations. Son Soo-jung,…
Windward Bio Group AG plans to raise over $100 million through a U.S. IPO to support the development of its clinical-stage asthma drug, WIN378, which has shown promising Phase 2/3 results. The company expects pivotal trial data by mid-2027 and targets the growing severe asthma…
Posted by Danessa Lincoln on Nov 6th, 2026 Here are the key takeaways from ANI Pharmaceuticals’ conference call: Here are the key news stories impacting ANI Pharmaceuticals this week: View Our Latest Stock Analysis on ANI Pharmaceuticals ANI’s portfolio includes branded products…
The Joplin Globe - Download the Globe app to my phone or tablet Frost Advisory from SAT 12:00 AM CST until SAT 8:00 AM CST UL Solutions announced its collaboration on a cross-industry proposal to the U.S. Food and Drug Administration that recommends modernizing…
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
An article joins this feed when it matches these terms. Each one is also a search of its own.